Prognica featured in Entrepreneur Middle East

Read Full Article on: Entrepreneur Middle East Magazine

 

 

 

 

 

 

UAE-Based Prognica Labs Uses Artificial Intelligence To Detect Masses In Mammography Screenings

In 2020, Nature.com published how researchers from Imperial College London and Google Health made use of artificial intelligence (AI) to spot abnormalities on x-ray images from nearly 29,000 women, with results showing how the algorithm outperformed six radiologists in reading mammograms. With this being an indication of the theoretical potential for AI to be able to detect cancer earlier with greater accuracy, it also presents an opportunity that UAE-based healthtech startup Prognica Labs is hoping to tap into in the GCC region.

Launched in 2019 by Khalid Shaikh, Prognica Labs is on a mission to improve clinical outcomes and accelerate the discovery of advancements in the fight against cancer. The startup is building a smart screening solution that analyzes medical images and generates insights to help predict and detect early cancer signs using AI and machine learning. Given the complexities involved in different types of cancer, Prognica Labs has chosen to start with a focus on breast cancer. According to the World Health Organization (WHO), 21 million women are impacted each year worldwide by breast cancer.

And if we take a look at statistics closer to home, the startup found that in the UAE, more than 75% of breast cancer patients only seek medical advice after experiencing a sign or symptom of the disease and many seek such advice late. The lack of awareness about symptoms of breast cancer and routine screening has also an important effect on symptom appraisal and decision- making regarding options for treatment. The team at Prognica Labs also found that many breast cancer patients aged 35-70 years old have experienced delayed treatment following the symptomatic recognition of breast cancer, and the time interval between the initial experience of symptoms related to the disease and seeking medical help ran from three months to three years.

Read More

Prognica Labs Joins NVIDIA Inception

Dubai, UAE — December 09, 2020 — Prognica Labs today announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in AI and data sciences.

Breast cancer is the most commonly diagnosed cancer in women (24.2%, i.e. about one in 4 of all new cancer cases diagnosed in women worldwide are breast cancer). Approximately 2.1 million women were diagnosed with breast cancer in 2018, according to a WHO report. In developing countries, more than 50% of the women who are detected with breast cancer end up losing their lives within a year.

Examining medical images and data is time-consuming and relies on the judgment and skills of highly specialized experts and many a time the interpretation is prone to errors since humans suffer from factors like fatigue and distractions. This is why patients sometimes have different interpretations from various doctors, which can make choosing a plan of action a stressful and tedious process.

Prognica is addressing these issues through our AI-powered platform, which can analyze medical images and generate medical reports — from anywhere and with complete accuracy.

NVIDIA Inception will allow Prognica to better collaborate with many other cutting-edge Artificial Intelligence and machine learning startups by leveraging valuable go-to-market support, expertise, and technology. Joining this program will help and support Prognica Labs’ Computer Vision and Machine Learning solutions. The program will also offer Prognica the opportunity to collaborate with industry-leading experts and other AI-driven organizations.

Khalid Shaikh, CEO, Founder of Prognica Labs said –
“Prevention and early detection are central to our mission of helping save lives, celebrate lives, and lead the fight against cancer. We are developing an adjunct, precision tool for mammography and ultrasound to equip radiologists with the objective, data-driven results they need to support patients and their healthcare team as they make decisions about their breast cancer screening, treatment, and diagnosis. We expect our participation in NVIDIA’s Inception program to push the limits of innovation with AI-based medical diagnosis to greater heights to serve the global society.”

NVIDIA Inception is a program that helps startups during critical stages of product development, prototyping, and deployment. Every Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute credits, marketing support, and technical assistance, which provides startups with the fundamental tools to help them grow.


Contact:
Prognica Labs
Khalid Shaikh (Founder, CEO)
Khalid@prognica.com

Read More

Dr. Menna Shaher Joins Prognica Labs’ Advisory Board

Dubai, UAE — December 16, 2020 — Prognica Labs, a Dubai based AI powered health-tech startup aiming to improve clinical outcomes in the fight against breast cancer using artificial intelligence and deep learning, today announced that Dr. Menna Shaher, has joined as an Advisor.

Dr. Menna has over 15 years of experience as a Breast Radiologist, 11 years of which as a Consultant Breast Imaging and Intervention Radiology.

Her areas of expertise includes Breast Mammography, early detection of breast cancer, Tomosynthesis, Contrast Enhanced mammography and Dynamic MRI breast with contrast, Breast and axilla ultrasound with Elastography, Breast interventional studies as biopsy and aspiration & total suction of benign lesions by Vacuum Assist Biopsy (VAB).

Dr. Menna completed MBBS, Masters in Radiodiagnosis & Intervention and Medical Doctorate in Diagnostic Radiology from Ain Shams University, Cairo, Egypt and Advanced Hospital Management Diploma from Canadian International Academy for advanced studies, Ottawa, Canada. She is a member in the European Society of Breast Imaging. She is also the founder and head of Breast Unit of Al Zahra Hospital in Sharjah.

“With her vast experience and passion in breast cancer space, along with the combination of strategic expertise, it will be of a tremendous resource in helping Prognica accelerate its vision in serving the society.” said Khalid Shaikh, Founder CEO at Prognica.

I’m honored to be working with the Prognica team as they are tackling a long term goal by working on breast cancer screening and diagnostics to make it more accurate, affordable and accessible.” Dr. Menna said. “I believe in networking and that joining forces can make miracles, also I admire the hard work and ideas Prognica is trying to implement. Looking forward to do more together.

Read More